Literature DB >> 7364927

The nondeiodinative pathways of thyroxine metabolism: 3,5,3',5-tetraiodothyroacetic acid turnover in normal and fasting human subjects.

C S Pittman, T Shimizu, A Burger, J B Chambers.   

Abstract

Complete turnover studies of T4, T3, rT3, and 3,5,3',5-tetriodothyroacetic acid (TA4) were carried out in normal subjects given T4 (0.2 mg, by mouth daily) by the integration method. When compared to the five fed controls, the four fasting subjects showed a decrease of mean T3 disposal from 41 to 18 micrograms/day, an increase of mean rT3 disposal from 49 to 61 micrograms/day. The mean serum TA4 concentration rose from 53 to 112 ng/dl, while the TA4 metabolic clearance remained unchanged. The fraction of T4 metabolized by deiodination changed from 79.0% to 77.5% in the fasting subjects as the fraction of T4 metabolized by deamination changed from 1.1% to 2.2%. Therefore, fasting induces a significant shunting of T4 away from T3 production into rT3 and TA4 production. However, oxidative deamination remains a minor metabolic pathway of T4 in man during both normal and fasting conditions. Given its low disposal rate and low biological potency, the increased TA4 production during fasting is probably not the inhibitory factor of TSH response to the lowered T3 production during fasting.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7364927     DOI: 10.1210/jcem-50-4-712

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  The disposition of SK&F L-94901, a selective thyromimetic in rat, dog and cynomolgus monkey.

Authors:  M A Pue; J A Ransley; D J Writer; A J Dean; E R Franklin; I G Beattie; D A Ross
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jul-Sep       Impact factor: 2.441

Review 2.  Novel thyroid hormones.

Authors:  Riccardo Zucchi; Grazia Rutigliano; Federica Saponaro
Journal:  Endocrine       Date:  2019-07-20       Impact factor: 3.633

3.  Alterations in 3,3'5'-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man.

Authors:  J S LoPresti; A Eigen; E Kaptein; K P Anderson; C A Spencer; J T Nicoloff
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

4.  Iodothyronamines are oxidatively deaminated to iodothyroacetic acids in vivo.

Authors:  Warren J L Wood; Travis Geraci; Aaron Nilsen; Andrea E DeBarber; Thomas S Scanlan
Journal:  Chembiochem       Date:  2009-01-26       Impact factor: 3.164

Review 5.  A Review of the Pharmacokinetics of Levothyroxine for the Treatment of Hypothyroidism.

Authors:  Philippe Colucci; Corinne Seng Yue; Murray Ducharme; Salvatore Benvenga
Journal:  Eur Endocrinol       Date:  2013-03-15

Review 6.  Actions of Thyroid Hormone Analogues on Chemokines.

Authors:  Paul J Davis; Gennadi V Glinsky; Hung-Yun Lin; Shaker A Mousa
Journal:  J Immunol Res       Date:  2016-07-17       Impact factor: 4.818

Review 7.  Thyroid Allostasis-Adaptive Responses of Thyrotropic Feedback Control to Conditions of Strain, Stress, and Developmental Programming.

Authors:  Apostolos Chatzitomaris; Rudolf Hoermann; John E Midgley; Steffen Hering; Aline Urban; Barbara Dietrich; Assjana Abood; Harald H Klein; Johannes W Dietrich
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-20       Impact factor: 5.555

Review 8.  Levothyroxine Treatment and the Risk of Cardiac Arrhythmias - Focus on the Patient Submitted to Thyroid Surgery.

Authors:  Zoran Gluvic; Milan Obradovic; Alan J Stewart; Magbubah Essack; Samantha J Pitt; Vladimir Samardzic; Sanja Soskic; Takashi Gojobori; Esma R Isenovic
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-04       Impact factor: 5.555

9.  TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis.

Authors:  Johannes W Dietrich; Gabi Landgrafe; Elisavet H Fotiadou
Journal:  J Thyroid Res       Date:  2012-12-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.